February 19, 2019
RegMed Investors’ (RMi) pre-open: a short week that’s back on the roller-coaster
February 15, 2019
RegMed Investors’ (RMi) pre-open: the known and the unknowns
February 14, 2019
RegMed Investors’ (RMi) pre-open: another missed data event as a hammer falls
February 13, 2019
RegMed Investors’ (RMi) pre-open: market actions compel focus to be on short-termism
February 12, 2019
RegMed Investors’ (RMi) pre-open: science will eventually win the battle of disease
February 11, 2019
RegMed Investors’ (RMi) pre-open: what’s new, sector anticipates Q4 and FY18 results, per share pricing losses, cash positions and “runways”
February 8, 2019
RegMed Investors’ (RMi) pre-open: oversold or overbought – when pricing reaches extreme levels, reversal are more than possible
February 7, 2019
RegMed Investors’ (RMi) pre-open: Lack of indications, quarterly results, dosing issues sow investor dissonance
February 6, 2019
RegMed Investors’ (RMi) pre-open: pressures could be brought to bear
February 5, 2019
RegMed Investors’ (RMi) pre-open: how long can the sector stay up?
February 4, 2019
RegMed Investors’ (RMi) pre-open: I have fundamental concerns within the sector
February 1, 2019
RegMed Investors’ (RMi) pre-open: navigating the sector’s share pricing
January 31, 2019
RegMed Investors’ (RMi) pre-open: anticipation, the danger of expectation
January 30, 2019
RegMed Investors’ (RMi) pre-open: the sector’s share pricing has been concentrated in low volume
January 29, 2019
RegMed Investors’ (RMi) pre-open: sector risks vary resulting from low volume and steep declines
January 28, 2019
RegMed Investors’ (RMi) pre-open: keeping an eye on last week’s high flyers and the dogs of the sector
January 25, 2019
RegMed Investors’ (RMi) pre-open: low volume upswing is a sign of the times
January 24, 2019
RegMed Investors’ (RMi) pre-open: I’m sticking to an oversold sector thesis
January 23, 2019
RegMed Investors’ (RMi) pre-open: the phoenix rises as “some” of the CRISPRs upsurge
January 22, 2019
RegMed Investors’ (RMi) pre-open: performance anxiety
January 18, 2019
RegMed Investors’ (RMi) pre-open: selective evidence
January 17, 2019
RegMed Investors’ (RMi) pre-open: an epidemic of caution
January 16, 2019
RegMed Investors’ (RMi) pre-open: upside share pricing leaps” keep the roof on
January 15, 2019
RegMed Investors’ (RMi) pre-open: the financing window is open
January 14, 2019
RegMed Investors’ (RMi) pre-open: what’s there to chew on?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.